The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients
Philp D, Badamchian M, Scheremeta B, et al.
Annals of the New York Academy of Sciences, 2012
Key finding
Thymosin beta-4 accelerated wound healing by nearly a month in Phase 2 human trials for chronic ulcers — the most advanced human clinical data for this compound.
Summary
Phase 2 clinical trials in venous stasis and pressure ulcers showing topical Tβ4 accelerated healing by nearly a month in patients who healed. Safe and well-tolerated.
Read the study
The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.
View on PubMedRelated compound
More research on TB-500
TB-500 Improves Neurological Recovery After Traumatic Brain Injury
Journal of Neurotrauma · 2011 · Animal Study
Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications
Expert Opinion on Biological Therapy · 2010 · Review
Thymosin Beta-4 Regulates Inflammation and Promotes Macrophage M2 Polarization
Journal of Molecular Medicine · 2010 · In Vitro
Thymosin beta4 and cardiac repair
Annals of the New York Academy of Sciences · 2009 · Animal Study
Thymosin Beta-4 Enhances Bone Healing in Fracture Model
Bone · 2009 · Animal Study